Pain and Split-belt Motor Learning in Older Adults
Launched by UNIVERSITY OF DELAWARE · Jun 27, 2025
Trial Information
Current as of July 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This study is looking at how short-term pain affects the ability of older adults to learn and remember new walking patterns. To do this, researchers will create a mild, temporary pain using a substance called capsaicin (the spicy part of chili peppers) combined with heat, and then see how this pain influences how well participants can adapt their walking on a special treadmill with two belts moving at different speeds.
If you are between 55 and 90 years old, generally healthy, and comfortable speaking and reading English, you might be eligible. Participants should not have serious health problems, ongoing pain, or conditions that affect thinking, balance, or movement. During the study, you will be asked to attend several testing sessions and may experience mild, temporary pain on your skin as part of the research. It’s important to know that this study is not yet recruiting volunteers, and certain health conditions or recent falls may exclude someone from participating to keep everyone safe.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 55-90 years old
- • Self-identifying as generally medically healthy
- • Able to read, write and speak English
- • Able to provide informed consent and attend all testing sessions
- • Willing to undergo the experimental pain paradigm, if selected
- Exclusion Criteria:
- • Resting heart rate \< 50 or \> 100 bpm
- • Resting blood pressure \< 90/60 or \> 165/95
- • Any history or current mental health condition, learning/developmental disability or cognitive impairment, including severe untreated ADD/ADHD, severe untreated anxiety, severe untreated depression, autism spectrum disorder, insomnia, mild cognitive impairment, etc. (Mild to moderate treated ADD/ADHD, anxiety, and/or depression are allowed.)
- • Score on the Montreal Cognitive Assessment (MoCA) \<23
- • Score on the Generalized Anxiety Disorder-7 Scale ≥ 10
- • Score on the Patient Health Questionnaire-2 ≥ 2 and score on the Patient Health Questionnaire-9 ≥ 10
- • Any current (within last 3 month) or chronic medical conditions, including any musculoskeletal, cardiovascular, pulmonary, metabolic, psychiatric or neurological diagnosis that affects activities of daily living or would confound testing or place the subject at risk by participating, such as a significant cardiovascular condition or event (e.g., heart attack \< 3 months ago, uncontrolled atrial fibrillation, uncontrolled angina, congestive heart failure, chronic obstructive pulmonary disorder, or peripheral vascular disease)
- • Any impaired sensation or weakness in either lower extremity
- • History of serious concussion or head injury, defined as a loss of consciousness for \> 5 minutes and/or requiring medical treatment, or \> 2 concussions over the lifespan
- • Any history of acute or chronic problems with balance, any dizziness, or \> 1 fall in the last 12 months
- • Currently or regularly using any analgesic medications, over-the-counter remedies, or any other treatment for the purposes of pain relief (i.e., baby aspirin for heart health is allowed)
- • Any current or chronic pain condition during the last year, located anywhere in the body with an intensity of \> 2/10
- • Allergy to capsaicin or hot peppers
- • Any skin lesion, breakage or irritation in the area targeted for the painful stimulus
- • Significant skin sensitivity to soaps/creams/perfumes or to heat
- • Poor circulation in the area targeted for the painful stimulus
- • Prior participation in a split-belt locomotor learning study in the Neuromotor Behavior Lab in the past 2 years
About University Of Delaware
The University of Delaware, a renowned research institution, is dedicated to advancing medical knowledge and improving patient care through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university leverages its expertise in various fields, including health sciences, engineering, and behavioral health, to conduct rigorous and ethical research. The university's commitment to scientific excellence and community engagement ensures that its clinical trials not only contribute to groundbreaking discoveries but also prioritize participant safety and well-being. Through its state-of-the-art facilities and a team of experienced researchers, the University of Delaware is positioned to make significant contributions to the field of clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Newark, Delaware, United States
Patients applied
Trial Officials
Susanne Morton
Principal Investigator
University of Delaware
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported